Offerings // Atea Pharmaceuticals, Inc.

AVIR offering history

Every offering-related filing in Atea Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 310 filings back to Dec 11, 2013.

Last executed offering
Oct 30, 2020
424B4 — priced deal (shares or notes)
Last registration (announced)
Nov 7, 2024
S-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Nov 19, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Nov 7, 2024S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 12, 2022EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Nov 24, 2021S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Oct 30, 2020424B4EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Oct 29, 2020S-1MEFREGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Oct 29, 2020EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Oct 26, 2020S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Oct 23, 2020S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Oct 9, 2020S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
AVIR offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full AVIR workspace →
AVIR offering FAQ

When did AVIR last execute an offering?

Per SEC filings, Atea Pharmaceuticals, Inc.'s most recent priced offering document is a 424B4 filed 2020-10-30. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did AVIR last announce or register an offering?

The most recent registration is a S-3 filed 2024-11-07. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.